BDRX

Biodexa Pharmaceuticals

hedge funds and large institutions have $480K invested in Biodexa Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Shares
Change %
CL
1
CSS LLC
Illinois
$262K
Renaissance Technologies
2
Renaissance Technologies
New York
$201K
UBS Group
3
UBS Group
Switzerland
$12K
Group One Trading
4
Group One Trading
Illinois
$3K
TRCT
5
Tower Research Capital (TRC)
New York
$1K
US Bancorp
6
US Bancorp
Minnesota
$1K